The open index of psychedelic research

An EEG-based evaluation of antidepressant effects of ketamine enantiomers and metabolites in monkeys.

Pinkley N

Aquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression.

Tobel T, Cone A, Choquette E +8

Real-World Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Retrospective Observational Study.

Ali MAS, Amirthalingam P, Alshareef H +4

Non-suicidal self-injury and other key predictors of suicide deaths among children and adolescents in England: a population-based case-control study.

Wong BH, Odd D, Luyt K +7

Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases

Sarvi M, Sarparast A

Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.

Tiwari P, Jenkins BW, Moore CF +4

Case report of S-ketamine as treatment option for suicidal ideation and treatment-resistant depression in adolescents with early-onset psychosis.

Schmelzle N, Neubacher K, Plener PL +1

Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprise

De Filippo R, Gillis R, Wyrick D +26

Safety and Efficacy of Remimazolam Combined with Esketamine for Anesthesia in Elderly Patients Undergoing ERCP: A Randomized Controlled Trial.

Yu Y, Wang J, Zhang Q +4

Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling.

Liu D, Li G, Huang H +3

Syntheses and structures of two norpsilocin derivatives: <i>N</i>-ethyl-4-hy-droxy-tryptamine (4-HO-NET) and 4-hy-droxy-<i>N</i>-propyl-tryptamine (4-HO-NPT).

Naeem M, Chadeayne AR, Golen JA +1

Mystical and affective features of naturalistic psychedelic experiences: A comparison of dictionary-based and LLM-based text analysis methods

Milczanowski A

As Psychedelic Treatments Get Leaner, Patients' Social Environments Deserve Attention.

Jacobs E, Roullier I, Watts R +1

Salvinorin A in humans: A systematic review of pharmacokinetics, pharmacodynamics, and safety.

Zürrer WE, Liesner J, Brüschweiler D +3

Bridging the gut and mind: a narrative review of depression in Crohn's disease and emerging gut-brain axis therapies.

Pipa Z, Howard N

Low Dose Ketamine Preconditions Astrocyte Mitochondria to Achieve Antidepressant Efficacy via Adenosine, Humanin, and Melatonin Upregulation and Efflux.

Anderson G

S-ketamine dampens effector T-cell function, thereby promoting tumor progression.

Niu D, Wang L, Wei R +1

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

Investigation of Potential Therapeutic Effects of New Rapid-Acting Antidepressant Drugs (RAADs) Using Stress-Based Models of Depression.

Pałucha-Poniewiera A

The impact of taking both ketamine and ADHD medication in under-18s: a scoping review protocol

Beyond discrimination: A systematic review of empirical studies assessing racial trauma and race-based traumatic stress.

Jurado EF, Low C, Benuto LT

Gut-brain axis immune modulation triggered by fungi drives PVT activation and OCD-like behavior

Pan, Xiangyu

Clinicians’ Attitudes and Opinions About Psychedelics in the SWANA Region: A Cross-Sectional Online Survey

Psychedelic Therapy without Durable Effects: A Review and Re-Evaluation of Controlled Studies between 1965-1977